Tablets could make treatment more mainstream, with sector predicted to be worth $200bn by end of the decade Tablets could make treatment more mainstream, with sector predicted to be worth $200bn by end of the decade “I just felt slow: I want to be able to do anything my kids want to do and not have weight be a factor. Even a ride or a water park – things have weight limits,” says Melody Ewert, 44, from Minnesota. Ewert has just switched from Eli Lilly’s Zepbound weekly injection to Novo Nordisk’